164 related articles for article (PubMed ID: 35918240)
1. "No Big Deal": A Qualitative Study of Pharmacists' Perspectives on Dispensing Mifepristone for Medication Abortion.
Kaller S; Ma M; Gurazada T; Baba CF; Rafie S; Raine-Bennett T; Averbach S; Chen M; Berry E; Meckstroth KR; Grossman D
Womens Health Issues; 2022; 32(6):571-577. PubMed ID: 35918240
[TBL] [Abstract][Full Text] [Related]
2. Pharmacists' knowledge, perspectives, and experiences with mifepristone dispensing for medication abortion.
Kaller S; Morris N; Biggs MA; Baba CF; Rafie S; Raine-Bennett TR; Creinin MD; Berry E; Micks EA; Meckstroth KR; Averbach S; Grossman D
J Am Pharm Assoc (2003); 2021; 61(6):785-794.e1. PubMed ID: 34281806
[TBL] [Abstract][Full Text] [Related]
3. Pharmacists' experiences dispensing misoprostol and readiness to dispense mifepristone.
Ferketa M; Moore A; Klein-Barton J; Stulberg D; Hasselbacher L
J Am Pharm Assoc (2003); 2024; 64(1):245-252.e1. PubMed ID: 37913990
[TBL] [Abstract][Full Text] [Related]
4. Dispensing mifepristone for medical abortion in Canada: Pharmacists' experiences of the first year.
Zusman EZ; Munro S; Norman WV; Soon JA
Can Pharm J (Ott); 2023; 156(4):204-214. PubMed ID: 37435503
[TBL] [Abstract][Full Text] [Related]
5. Mailing abortion pills does not delay care: A cohort study comparing mailed to in-person dispensing of abortion medications in the United States.
Koenig LR; Raymond EG; Gold M; Boraas CM; Kaneshiro B; Winikoff B; Coplon L; Upadhyay UD
Contraception; 2023 May; 121():109962. PubMed ID: 36736715
[TBL] [Abstract][Full Text] [Related]
6. Medication abortion: Potential for improved patient access through pharmacies.
Raifman S; Orlando M; Rafie S; Grossman D
J Am Pharm Assoc (2003); 2018; 58(4):377-381. PubMed ID: 29752204
[TBL] [Abstract][Full Text] [Related]
7. Pharmacist dispensing of the abortion pill in Canada: Diffusion of Innovation meets integrated knowledge translation.
Munro S; Wahl K; Soon JA; Guilbert E; Wilcox ES; Leduc-Robert G; Ansari N; Devane C; Norman WV
Implement Sci; 2021 Aug; 16(1):76. PubMed ID: 34344393
[TBL] [Abstract][Full Text] [Related]
8. Expanding access to medication abortion through pharmacy dispensing of mifepristone: Primary care perspectives from Illinois.
Rasmussen KN; Janiak E; Cottrill AA; Stulberg DB
Contraception; 2021 Jul; 104(1):98-103. PubMed ID: 33781760
[TBL] [Abstract][Full Text] [Related]
9. Pharmacist direct dispensing of mifepristone for medication abortion in Canada: a survey of community pharmacists.
Zusman EZ; Munro S; Norman WV; Soon JA
BMJ Open; 2022 Oct; 12(10):e063370. PubMed ID: 36207038
[TBL] [Abstract][Full Text] [Related]
10. Mifepristone (RU486) in Australian pharmacies: the ethical and practical challenges.
Lee RY; Moles R; Chaar B
Contraception; 2015 Jan; 91(1):25-30. PubMed ID: 25248673
[TBL] [Abstract][Full Text] [Related]
11. Medication Abortion With Pharmacist Dispensing of Mifepristone.
Grossman D; Baba CF; Kaller S; Biggs MA; Raifman S; Gurazada T; Rafie S; Averbach S; Meckstroth KR; Micks EA; Berry E; Raine-Bennett TR; Creinin MD
Obstet Gynecol; 2021 Apr; 137(4):613-622. PubMed ID: 33706339
[TBL] [Abstract][Full Text] [Related]
12. Medication abortion: Advocating for mifepristone dispensing by pharmacists.
Stone RH; Rafie S
Contraception; 2021 Jul; 104(1):31-32. PubMed ID: 33971150
[No Abstract] [Full Text] [Related]
13. Mail-Order Pharmacy Dispensing of Mifepristone for Medication Abortion After In-Person Screening.
Grossman D; Raifman S; Morris N; Arena A; Bachrach L; Beaman J; Biggs MA; Collins A; Hannum C; Ho S; Seibold-Simpson SM; Sobota M; Tocce K; Schwarz EB; Gold M
JAMA Intern Med; 2024 May; ():. PubMed ID: 38739404
[TBL] [Abstract][Full Text] [Related]
14. Obstetrician-gynecologist willingness to provide medication abortion with removal of the in-person dispensing requirement for mifepristone.
Daniel S; Schulkin J; Grossman D
Contraception; 2021 Jul; 104(1):73-76. PubMed ID: 33811840
[TBL] [Abstract][Full Text] [Related]
15. Pharmacy Provision of Medication Abortion in Nepal: Pharmacy Owner and Worker Perspectives.
Samari G; Puri M; Cohen R; Blum M; Rocca CH
Int Perspect Sex Reprod Health; 2018 Sep; 44(3):81-89. PubMed ID: 30698524
[TBL] [Abstract][Full Text] [Related]
16. Mifepristone by prescription: a dream in the United States but reality in Australia.
Grossman D; Goldstone P
Contraception; 2015 Sep; 92(3):186-9. PubMed ID: 26096369
[TBL] [Abstract][Full Text] [Related]
17. Mail-order pharmacy dispensing of mifepristone for medication abortion after in-person clinical assessment.
Grossman D; Raifman S; Morris N; Arena A; Bachrach L; Beaman J; Biggs MA; Hannum C; Ho S; Schwarz EB; Gold M
Contraception; 2022 Mar; 107():36-41. PubMed ID: 34555420
[TBL] [Abstract][Full Text] [Related]
18. Primary care and abortion provider perspectives on mail-order medication abortion: a qualitative study.
Raifman S; Gurazada T; Beaman J; Biggs MA; Schwarz EB; Gold M; Grossman D
BMC Womens Health; 2024 Jul; 24(1):382. PubMed ID: 38956609
[TBL] [Abstract][Full Text] [Related]
19. A qualitative analysis of pharmacists' attitudes towards provision of medication abortion.
Sandoval S; Chen G; Rafie S; Rabin B; Mody S; Averbach S
BMC Health Serv Res; 2023 May; 23(1):557. PubMed ID: 37254171
[TBL] [Abstract][Full Text] [Related]
20. Determinants of community pharmacists' quality of care: a population-based cohort study using pharmacy administrative claims data.
Winslade N; Tamblyn R
BMJ Open; 2017 Sep; 7(9):e015877. PubMed ID: 28939571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
